Next Article in Journal
Protective Roles of Gadd45 and MDM2 in Blueberry Anthocyanins Mediated DNA Repair of Fragmented and Non-Fragmented DNA Damage in UV-Irradiated HepG2 Cells
Next Article in Special Issue
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Previous Article in Journal
MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
Previous Article in Special Issue
Lessons from Mouse Models of High-Fat Diet-Induced NAFLD
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(11), 21435-21446;

Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes

Institutes of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
Seventh Department of Internal Medicine, Linyi People's Hospital, Linyi 276000, Shandong, China
Department of Gastroenterology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 18 July 2013 / Revised: 11 September 2013 / Accepted: 12 September 2013 / Published: 29 October 2013
(This article belongs to the Special Issue Non-Alcoholic Fatty Liver Disease Research)
Full-Text   |   PDF [372 KB, uploaded 19 June 2014]


Non-alcoholic fatty liver disease (NAFLD) is characterized by triglyceride (TG) accumulation in hepatocytes. Very low density lipoprotein (VLDL) is a major secretory product of the liver that transports endogenously synthesized TG. Disrupted VLDL secretion may contribute to the accumulation of TG in hepatocytes. ApoB100 (apolipoprotein B100) is a glycoprotein and an essential protein component of VLDL. Its glycosylation may affect VLDL assembly and secretion. However, which glycosyltransferase catalyzes apoB100 glycosylation is unknown. In this study, we cloned the GLT8D2 (glycosyltransferase 8 domain containing 2) gene from HepG2 cells and generated a series of plasmids for in vitro studies of its molecular functions. We discovered that GLT8D2 was localized in the ER, interacted with apoB100, and positively regulated the levels of apoB100 protein in HepG2 cells. Based on these results, we propose that GLT8D2 is a glycosyltransferase of apoB100 that regulates apoB100 levels in hepatocytes. View Full-Text
Keywords: non-alcoholic fatty liver disease; glycosyltransferase; GLT8D2; apoB100 non-alcoholic fatty liver disease; glycosyltransferase; GLT8D2; apoB100
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Wei, H.-S.; Wei, H.-L.; Zhao, F.; Zhong, L.-P.; Zhan, Y.-T. Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes. Int. J. Mol. Sci. 2013, 14, 21435-21446.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top